Horan Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-200
Closed -$20K 253
2019
Q3
$20K Hold
200
0.02% 123
2019
Q2
$18K Hold
200
0.02% 128
2019
Q1
$19K Hold
200
0.02% 115
2018
Q4
$17K Hold
200
0.02% 114
2018
Q3
$16K Hold
200
0.02% 102
2018
Q2
$17K Hold
200
0.02% 99
2018
Q1
$18K Hold
200
0.02% 92
2017
Q4
$21K Hold
200
0.02% 84
2017
Q3
$28K Hold
200
0.03% 64
2017
Q2
$27K Hold
200
0.03% 62
2017
Q1
$25K Buy
+200
New +$23.9K 0.03% 58
2016
Q4
Sell
-200
Closed -$20K 158
2016
Q3
$20K Buy
+200
New +$21.6K 0.03% 61

Other funds holding CELG

Horan Securities's CELG Position: Q4 2019 in Review

Horan Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 200 shares — an estimated $20K sold.

Horan Securities first reported a position in CELG in Q3 2016 and held it in 12 quarters. The position peaked at $28K in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Horan Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Horan Securities sold 200 Celgene Corp shares in Q4 2019, an estimated $20K.
  • Horan Securities first reported a position in Celgene Corp in Q3 2016 and held it in 12 quarters.
  • Horan Securities's Celgene Corp position peaked at $28K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Horan Securities's 13F filing for Q4 2019, filed 5 Feb 2020.